Trial Information
Including Patient Preferences in Symptom Management of Cancer Patients: A Randomized Clinical Trial
as above
Inclusion Criteria:
- Starting treatment for a newly diagnosed acute myelogenous leukemia (AML), lymphatic
leukemia (ALL), Hodgkin or non-Hodgkin lymphoma, or
- starting treatment for a recurrence of the disease;
- starting treatment with allogenous or autologous Stem Cell Transplantation (SCT).
- above 18 years of age.
Exclusion Criteria:
- having received radiation on the brain
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Supportive Care
Outcome Measure:
Physicians' and nurses' symptom-related chart entries in patients' records
Outcome Time Frame:
In-patient episodes of care
Safety Issue:
No
Principal Investigator
Cornelia M Ruland, PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Rikshospitalet-Radiumhospitalet
Authority:
Norway:National Committee for Medical and Health Research Ethics
Study ID:
RCN 154739/320
NCT ID:
NCT00709813
Start Date:
December 2003
Completion Date:
December 2005
Related Keywords:
- Cancer
- Lymphoma
- Leukemia
- Stem Cell Transplantation
- Symptom management
- Cancer
- Patient-centered care
- Leukemia
- Lymphoma